osteoporosis-delaware-badge-of-top-doctor-in-2024-2025

Delaware Osteoporosis
Infusion Center of DE

Infusion Center of DE provides specialized osteoporosis care in Delaware, including personalized treatment plans and infusion therapy to help strengthen bones and reduce the risk of fractures. Our rheumatology team serves patients in Wilmington, Dover, and Milford.

Osteoporosis Treatment in Delaware

Osteoporosis is a bone disease that causes bones to become weaker and more likely to fracture. Because bone loss often develops without obvious symptoms, many people do not know they have osteoporosis until a bone-density test identifies it or a fracture occurs.

At Infusion Center of Delaware, patients can receive evaluation and treatment for osteoporosis as part of an individualized bone-health plan. Depending on your diagnosis, fracture risk, medical history, and previous treatment, care may include lifestyle recommendations, osteoporosis medications, laboratory monitoring, injections, or physician-prescribed infusion therapy.

Doctor assisting the patient because of osteoporosis in delaware

Treatment is not the same for every patient. The goal is to understand your bone health, identify factors that increase fracture risk, and determine which treatment approach is medically appropriate for you.

What Is Osteoporosis?

Osteoporosis develops when bone mineral density and bone mass decrease enough to weaken the structure of the bones. Weaker bones are more vulnerable to fractures, particularly in the hip, spine, and wrist. Osteoporosis can affect both women and men, although risk increases with age and after menopause.

Bone is living tissue that is continuously being broken down and rebuilt. When bone loss occurs faster than new bone can replace it, bone strength can gradually decline.

This process usually does not cause pain by itself. That is one reason osteoporosis is sometimes described as a silent bone disease.

A fracture may be the first noticeable sign.

Why Can Osteoporosis Be Difficult to Detect?

Osteoporosis often develops without clear early symptoms. A person may feel healthy while bone density is gradually declining. Bone-density testing and assessment of individual fracture risk are therefore important for identifying osteoporosis before a serious fracture occurs.

As osteoporosis progresses, possible signs or consequences can include:

A fracture that occurs from a fall at standing height or another relatively low level of trauma may be described as a fragility fracture. A history of this type of fracture can be an important part of an osteoporosis evaluation.

What Causes Osteoporosis?

Osteoporosis develops when the balance between bone breakdown and bone formation changes enough to reduce bone strength. Aging and hormonal changes are common contributors, but medications, medical conditions, nutrition, lifestyle, and genetics can also affect bone health.

Some people develop osteoporosis primarily as part of aging and hormonal changes. Others have secondary osteoporosis, meaning another disease, medication, or health factor contributes to bone loss.

What Are the Risk Factors for Osteoporosis?

Factors associated with greater osteoporosis or fracture risk can include:

Having one or more risk factors does not automatically mean you have osteoporosis. A healthcare provider can consider your overall risk and determine whether testing or treatment is appropriate.

Concerned About Bone Density or Fracture Risk?

You do not have to wait for a fracture to discuss your bone health. An evaluation can help determine whether bone-density testing, additional laboratory testing, monitoring, or treatment should be considered.

How Is Osteoporosis Diagnosed?

Osteoporosis is diagnosed by evaluating bone mineral density, fracture history, medical history, medications, and other factors that influence bone strength. A dual-energy X-ray absorptiometry scan, usually called a DXA or DEXA scan, is commonly used to measure bone mineral density.

DXA or DEXA Bone-Density Testing

A DXA scan is a noninvasive test that uses low levels of X-rays to measure bone mineral density. Testing commonly focuses on the hip and spine because these areas are particularly important for assessing osteoporosis and fracture risk.

Bone-density testing may help a clinician:

What Does a T-Score Mean?

For many adults, DXA results include a T-score, which compares bone mineral density with the average bone density of a healthy young adult.

A T-score is only one part of the clinical picture. Your provider may also consider age, previous fractures, family history, medication use, medical conditions, and other fracture-risk factors before recommending treatment.

Is a DXA Scan the Only Test Needed?

Not always.

A clinician may review your complete medical and medication history and order laboratory testing when appropriate. Testing can help identify conditions that contribute to bone loss or determine whether a particular osteoporosis medication can be used safely.

Depending on the patient’s situation and proposed treatment, this may include evaluation of calcium levels, vitamin D status, kidney function, or other laboratory values.

How Is Osteoporosis Treated?

Osteoporosis treatment aims to maintain or improve bone strength and reduce the likelihood of future fractures. Treatment is individualized according to bone density, age, previous fractures, overall fracture risk, medical conditions, medications, and how a patient has responded to previous osteoporosis therapy.

An osteoporosis treatment plan may involve several components:

Medication is particularly important for some patients at increased risk of fracture.

What Medications Are Used to Treat Osteoporosis?

Osteoporosis medications work in different ways. Some reduce the rate at which bone is broken down, while others stimulate new bone formation. The appropriate medication depends on the patient’s fracture risk, health history, kidney function, previous treatment, potential side effects, and other clinical considerations.

Bisphosphonates

Bisphosphonates are a commonly used class of osteoporosis medications. They reduce bone breakdown and can help preserve bone density. Some bisphosphonates are taken orally, while others can be administered intravenously. Zoledronic acid (Reclast) is an IV bisphosphonate used for certain patients with osteoporosis. Whether Reclast is appropriate depends on the patient's diagnosis, kidney function, calcium status, medical history, and other factors reviewed by the prescribing clinician.

RANK Ligand Inhibitor Therapy

RANK ligand inhibition reduces the activity of cells responsible for breaking down bone. Denosumab (Prolia) is administered by injection rather than IV infusion and is used for certain patients at high risk for fracture. Treatment needs to follow the prescribed schedule, and patients should discuss medication changes or discontinuation with their healthcare provider rather than stopping treatment on their own.

Bone-Building Therapies

Some osteoporosis medications work primarily by stimulating new bone formation. These therapies may be considered for certain patients with severe osteoporosis or very high fracture risk. Medication selection should always be individualized. There is no single osteoporosis medication that is the best choice for every patient.

When May Infusion Therapy Be Considered for Osteoporosis?

Infusion therapy may be considered when a physician determines that an IV osteoporosis medication is appropriate for the patient’s diagnosis and fracture risk. It may also provide an alternative for certain patients when an oral treatment is not appropriate, is difficult to tolerate, or does not fit the prescribed treatment plan.

Infusion therapy delivers medication directly into a vein under clinical supervision. For osteoporosis, zoledronic acid (Reclast) is one example of a medication that may be administered intravenously.

An infusion is not automatically the right treatment simply because someone has osteoporosis. The prescribing clinician considers the patient’s bone-density results, fracture history, kidney function, calcium status, previous treatment, and other health factors before determining whether an IV medication is appropriate.

Already Diagnosed With Osteoporosis?

If your physician has recommended osteoporosis medication or you want to understand whether an infusion or injectable treatment may be appropriate, our team can help you navigate the next steps.

What Happens Before an Osteoporosis Infusion?

Before an osteoporosis infusion, the prescribing and infusion teams need to confirm that the medication is appropriate and that relevant safety requirements have been addressed. The exact process depends on the medication, your health history, laboratory results, and prescribing instructions.

Before treatment, your healthcare team may review:

Your Diagnosis and Fracture History

Your clinician may consider your DXA results, previous fractures, risk factors, and treatment history.

Kidney Function

Kidney function is particularly important before certain IV bisphosphonate treatments, including zoledronic acid.

Calcium and Vitamin D

Calcium and vitamin D status may need to be evaluated or addressed before treatment, depending on the medication and individual clinical circumstances.

Current Medications and Medical Conditions

Your provider should know about prescription medicines, over-the-counter medicines, supplements, kidney disease, dental concerns, and other relevant medical conditions.

Prescriber Order and Insurance Authorization

The infusion center may also need a valid prescription or treatment order and any required insurance authorization before treatment can be scheduled.

What Should I Expect During an Osteoporosis Infusion?

During an osteoporosis infusion, medication is administered through an intravenous line while you are monitored by clinical staff. The length of the appointment depends on the prescribed medication, required preparation, and your individual treatment plan.

Before treatment begins, staff may confirm your medication, medical information, and relevant laboratory results.

An IV is then placed, and the medication is administered according to the prescribed protocol.

Patients should tell the clinical team about any symptoms or concerns before, during, or after treatment. Your provider can also explain medication-specific side effects and precautions before therapy begins.

What Are the Benefits and Risks of Osteoporosis Treatment?

Osteoporosis treatment is intended to reduce fracture risk and protect bone health, but the expected benefits and potential risks differ among medications. Your healthcare provider should consider both when recommending therapy.

Potential benefits may include reducing bone loss, improving or maintaining bone mineral density, and lowering fracture risk depending on the medication.

Potential adverse effects vary considerably between therapies. Certain osteoporosis treatments can affect calcium levels, kidney function, or other aspects of health, while some have medication-specific precautions.

For this reason, treatment decisions should be made with a qualified healthcare provider rather than based only on a bone-density number.

Who's most at risk

Women over 50

Postmenopausal

Adults over 65

Thyroid disorders

Family history

Prior fracture

Smoking

Rheumatoid arthritis

Lupus

Heavy alcohol use

Low body weight

Long-term steroid use

Inactivity

How Is Osteoporosis Treatment Monitored?

Osteoporosis requires long-term management because bone health and fracture risk can change over time. Monitoring helps clinicians determine whether treatment remains appropriate and whether the patient’s risk factors or treatment plan have changed.

Monitoring may include:

Patients should also tell their healthcare provider about new fractures, significant changes in health, or concerns about treatment.

Can Osteoporosis Be Cured?

Osteoporosis is generally managed as a long-term condition rather than treated with the expectation of a simple cure. Treatment can help protect bone health and reduce fracture risk, and some medications can increase bone mineral density.

Improved bone-density results do not necessarily mean treatment should be stopped. Decisions about continuing, changing, pausing, or stopping medication depend on the specific therapy and the patient’s current fracture risk.

Do not stop a prescribed osteoporosis medication without discussing it with your healthcare provider.

Symptoms rarely show up early

Most people feel nothing until bone loss is significant. When signs do appear, they tend to look like this:

 

Back pain

From spinal compression fractures, often mistaken for ordinary strain.

Height loss

A gradual decrease in height over months or years.

 

Stooped posture

A hunched or forward-curving spine, sometimes called dowager’s hump.

 

Fractures from minor events

A break from a low fall or everyday activity that shouldn’t cause one.

Reduced mobility

Difficulty walking or climbing stairs after a fracture.

 

Chronic vertebral pain

Ongoing discomfort tied to fractures in the spine.

Four forces that tip the balance

Bone density naturally falls with age as remodeling slows, steadily raising fracture risk for everyone.

Women lose bone rapidly after menopause as estrogen drops. Men are affected too, typically later, as testosterone declines.

Low calcium intake, inadequate vitamin D, and general poor nutrition all weaken the raw material bone is built from.

Certain medical conditions and medications can contribute to bone loss. Long-term corticosteroid use is an important medication-related risk factor, and conditions affecting hormones, nutrition, kidney function, or inflammatory disease may also influence bone health.

Questions About Starting Treatment?

Our team can help you understand the next administrative steps for physician-prescribed osteoporosis treatment.

Osteopenia vs. Osteoporosis

Many patients are diagnosed with osteopenia first an early warning that reduced density is developing, before it becomes osteoporosis.

Osteopenia

Osteoporosis

Diagnosis, in four steps

We review prior fractures, family history, medications, exercise, calcium intake, and relevant conditions.

Assessing height loss, spinal alignment, balance, mobility, and signs of past fractures.

A painless, low-dose X-ray that measures bone mineral density and produces your T-score.

Who lives here

Delaware, by the numbers

Delaware has a substantial older-adult population, making bone health, fracture prevention, and appropriate osteoporosis screening especially relevant across the state.

1,051,917

residents, 2024
Delaware population

Sets the base population potentially affected by bone health conditions statewide.

22.8%

≈ 240,000 residents
Delaware population

The age group with the highest risk of osteoporosis and fragility fractures.

52.0%

of the population
Female population
Women face substantially greater osteoporosis risk, particularly after menopause.

28.1%

≈ 207,000 adults
Adults diagnosed with arthritis
Arthritis often coexists with osteoporosis, compounding fall and fracture risk.

Reading the data

Delaware bone health insight

The U.S. Census Bureau puts that figure at 22.8% of Delaware residents about 240,000 people. Since advancing age is one of the strongest risk factors for osteoporosis, this large older-adult population underscores the importance of early bone density screening, fracture prevention, and timely treatment.

The CDC’s Morbidity and Mortality Weekly Report estimates 28.1% of Delaware adults have been diagnosed with arthritis. Arthritis can reduce mobility and balance, raising the likelihood of falls and fractures among people who also have osteoporosis.

Delaware Health Statistics

Residents Age 65+
22.8%
Source: U.S. Census Bureau
Adults Diagnosed with Arthritis
28.1%
Source: CDC

Once diagnosed

Oral medication vs. IV infusion therapy

Oral medication

Tablet-based

IV infusion therapy

Clinician-administered
Daily, weekly, or monthly tablets
Daily, weekly, or monthly tablets
More common
Avoids the gastrointestinal tract
Requires strict dosing instructions
Administered by healthcare professionals
Higher
Lower — treatments are scheduled
Many patients with mild disease
Patients who can’t tolerate oral medication, face adherence challenges, or need long-acting treatment

When Should You See a Specialist About Osteoporosis?

Consider discussing osteoporosis with a qualified healthcare provider if you have been diagnosed with low bone density, experienced a fragility fracture, have significant osteoporosis risk factors, or need help determining which treatment is appropriate.

Specialist evaluation may also be useful when osteoporosis is severe, treatment decisions are complex, another medical condition may be contributing to bone loss, or previous treatment has not been well tolerated.

At Infusion Center of Delaware, osteoporosis care can include evaluation, medication management, monitoring, and administration of prescribed therapies when appropriate.

Why choose our infusion therapy team

Osteoporosis management involves more than receiving medication. Appropriate osteoporosis care may involve clinical evaluation, medication selection, laboratory review, treatment monitoring, and coordination among the patient, prescribing clinician, infusion team, and insurance provider.

Infusion Center of Delaware provides patients with access to rheumatology and infusion services within one care environment.

Meet Your Physician

Dr. Maged Hosny

More than 25 years of experience diagnosing and treating rheumatologic and musculoskeletal conditions, serving patients in Delaware and surrounding communities since 2000.

Our clinical team treats autoimmune and musculoskeletal conditions and provides access to biologic infusion therapy across three Delaware locations Wilmington, Dover, and Milford making ongoing appointments, lab monitoring, and recurring infusions more accessible statewide.

Areas Infusion Center of DE Serves in Delaware

Infusion Center of Delaware provides rheumatology and infusion services at locations in Wilmington, Dover, and Milford, helping patients access osteoporosis care closer to home.

Wilmington

Dover

Milford

Looking for Osteoporosis Care in Delaware?

Whether you have recently been diagnosed with osteoporosis, are concerned about fracture risk, or have been prescribed osteoporosis treatment, our team can help you determine the appropriate next step.

FAQS ABOUT OSTEOPOROSIS DELAWARE - INFUSION CENTER OF DE

Some osteoporosis medications can increase bone mineral density, while others primarily slow bone breakdown and reduce fracture risk. The expected response depends on the medication, severity of osteoporosis, previous fractures, and individual health factors. Bone-density testing and clinical monitoring can help providers evaluate how bone health changes during treatment.

Osteoporosis-related fractures commonly affect the hip, spine, and wrist, although other bones can also fracture. Vertebral fractures may sometimes occur without an obvious injury and can contribute to back pain, loss of height, or changes in posture. Preventing fractures is one of the primary goals of osteoporosis treatment.

Yes. Although osteoporosis is more common in women, particularly after menopause, men can also develop significant bone loss and osteoporosis. Aging, low hormone levels, certain medications, chronic diseases, smoking, alcohol use, and other factors can increase risk. Men with fractures or other risk factors should discuss bone health with their healthcare provider.

Not necessarily. Osteopenia means bone mineral density is lower than expected but has not reached the bone-density threshold typically used to define osteoporosis. Whether it progresses depends on age, medical conditions, medications, lifestyle, and other factors. A clinician can assess your overall fracture risk and recommend appropriate monitoring or preventive measures.

Osteoporosis itself often causes no symptoms, but fractures caused by weakened bones can be painful. Vertebral compression fractures in the spine may cause sudden or persistent back pain, loss of height, or changes in posture. New or severe back pain should be evaluated rather than automatically attributed to osteoporosis.

The appropriate interval between DXA scans depends on your initial results, age, fracture risk, medication, and treatment plan. Some patients require closer monitoring than others. Your healthcare provider can determine when repeat bone-density testing is likely to provide useful information for treatment decisions.

Yes, physical activity is generally an important part of osteoporosis management. Weight-bearing, resistance, and balance exercises can support strength and reduce fall risk. However, people with severe osteoporosis or previous fractures may need to avoid certain high-impact or forceful movements. Ask your healthcare provider which exercises are appropriate for you.

Take the Next Step in Your Bone Health

If you have osteoporosis, low bone density, a history of fragility fracture, or questions about a prescribed osteoporosis medication, schedule an evaluation to discuss your treatment options.

Scroll to Top